NCI study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis
An NCI study shows that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.





English (US) ·